Literature DB >> 21061072

The comparison of low and standard dose ACTH and glucagon stimulation tests in the evaluation of hypothalamo-pituitary-adrenal axis in healthy adults.

Zuleyha Karaca1, Ayhan Lale, Fatih Tanriverdi, Mustafa Kula, Kursad Unluhizarci, Fahrettin Kelestimur.   

Abstract

Evaluation of the HPA axis is still a challenge; due to different sensitivities and stimulation efficiencies of dynamic tests, lack of standard assays for cortisol measurement and lack of data regarding the effects of age and gender on the results of the HPA axis evaluation with different dynamic tests. This study was performed to compare 1 μg ACTH, 250 μg ACTH and glucagon tests in the evaluation of HPA axis. The study was carried out on 55 healthy individuals (28 men, 27 women). 10-12 volunteers were included from every decades between 20 and 70 years. Low dose short synacthen test (1 μg ACTH), standard dose short synacthen test (250 μg ACTH) and glucagon tests were performed consecutively. The mean peak cortisol response to standard dose ACTH stimulation test was found to be significantly higher than the low dose ACTH and glucagon stimulation tests. The mean peak cortisol responses to low dose ACTH and the glucagon stimulation tests were not significantly different. The mean peak cortisol responses did not differ significantly between different age or sex groups. The lowest peak cortisol responses obtained after low dose ACTH and glucagon stimulation tests were 12.5 and 9.1 μg/dl respectively in the volunteers who all had cortisol responses higher than 20 μg/dl after standard dose ACTH stimulation test. The lowest cortisol responses obtained during 250 μg ACTH, 1 μg ACTH and glucagon stimulation tests were found to be 20.1, 12.5 and 9.1 μg/dl in a known group of healthy people. So the consideration of appropriate hormonal cut-off levels for each test seems reasonable. The age, sex and body mass indeces were not shown to affect the cortisol response to dynamic stimulation tests. © Springer Science+Business Media, LLC 2010

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21061072     DOI: 10.1007/s11102-010-0270-3

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  25 in total

1.  Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test.

Authors:  G Dickstein; C Shechner; W E Nicholson; I Rosner; Z Shen-Orr; F Adawi; M Lahav
Journal:  J Clin Endocrinol Metab       Date:  1991-04       Impact factor: 5.958

2.  Comparison of the ACTH and cortisol responses to provocative testing with glucagon and insulin hypoglycaemia in normal subjects.

Authors:  M D Littley; S Gibson; A White; S M Shalet
Journal:  Clin Endocrinol (Oxf)       Date:  1989-11       Impact factor: 3.478

3.  Diagnostic utility of the glucagon stimulation test in comparison to the insulin tolerance test in patients following pituitary surgery.

Authors:  Christian Berg; Timo Meinel; Harald Lahner; Ali Yuece; Klaus Mann; Stephan Petersenn
Journal:  Eur J Endocrinol       Date:  2009-12-08       Impact factor: 6.664

Review 4.  Clinical review 62: Laboratory assessment of adrenal insufficiency.

Authors:  S K Grinspoon; B M Biller
Journal:  J Clin Endocrinol Metab       Date:  1994-10       Impact factor: 5.958

5.  Reliability of the 30-minute ACTH test in assessing hypothalamic-pituitary-adrenal function.

Authors:  J Lindholm; H Kehlet; M Blichert-Toft; B Dinesen; J Riishede
Journal:  J Clin Endocrinol Metab       Date:  1978-08       Impact factor: 5.958

6.  Kickboxing sport as a new cause of traumatic brain injury-mediated hypopituitarism.

Authors:  Fatih Tanriverdi; Kursad Unluhizarci; Bekir Coksevim; Ahmed Selcuklu; Felipe F Casanueva; Fahrettin Kelestimur
Journal:  Clin Endocrinol (Oxf)       Date:  2007-03       Impact factor: 3.478

7.  Assessing the HPA axis in patients with pituitary disease: a UK survey.

Authors:  Rebecca M Reynolds; Paul M Stewart; Jonathan R Seckl; Paul L Padfield
Journal:  Clin Endocrinol (Oxf)       Date:  2006-01       Impact factor: 3.478

8.  Assessing adrenal function in primary care settings with a single sample subcutaneous glucagon test.

Authors:  Michael S Kappy; Amanda Drake; Dexiang Gao; Rebecca Ratliff
Journal:  J Pediatr       Date:  2006-11       Impact factor: 4.406

9.  Corticotropin tests for hypothalamic-pituitary- adrenal insufficiency: a metaanalysis.

Authors:  Rasa Kazlauskaite; Arthur T Evans; Carmen V Villabona; Tariq A M Abdu; Bruno Ambrosi; A Brew Atkinson; Cheung Hei Choi; Richard N Clayton; C Hamish Courtney; E Nazli Gonc; Mohamad Maghnie; Susan R Rose; Steven G Soule; Karen Tordjman
Journal:  J Clin Endocrinol Metab       Date:  2008-08-12       Impact factor: 5.958

10.  The role of the low dose (1 microgram) adrenocorticotropin test in the evaluation of patients with pituitary diseases.

Authors:  K Tordjman; A Jaffe; N Grazas; C Apter; N Stern
Journal:  J Clin Endocrinol Metab       Date:  1995-04       Impact factor: 5.958

View more
  22 in total

1.  Three years prospective investigation of pituitary functions following subarachnoid haemorrhage.

Authors:  Z Karaca; F Tanriverdi; A T Dagli; A Selcuklu; F F Casanueva; K Unluhizarci; F Kelestimur
Journal:  Pituitary       Date:  2013-03       Impact factor: 4.107

2.  Tripartite control of dynamic ACTH-cortisol dose responsiveness by age, body mass index, and gender in 111 healthy adults.

Authors:  Johannes D Veldhuis; Ali Iranmanesh; Ferdinand Roelfsema; Paul Aoun; Paul Takahashi; John M Miles; Daniel M Keenan
Journal:  J Clin Endocrinol Metab       Date:  2011-07-13       Impact factor: 5.958

3.  Clinical characteristics, timing of peak responses and safety aspects of two dosing regimens of the glucagon stimulation test in evaluating growth hormone and cortisol secretion in adults.

Authors:  Kevin C J Yuen; Beverly M K Biller; Laurence Katznelson; Sharon A Rhoads; Michelle H Gurel; Olivia Chu; Valentina Corazzini; Kellie Spiller; Murray B Gordon; Roberto Salvatori; David M Cook
Journal:  Pituitary       Date:  2013-06       Impact factor: 4.107

4.  Characterization of the serum and salivary cortisol response to the intravenous 250 µg ACTH1-24 stimulation test.

Authors:  Brendan J Nolan; Jane Sorbello; Nigel Brown; Goce Dimeski; Warrick J Inder
Journal:  Endocrine       Date:  2018-01-03       Impact factor: 3.633

5.  Comparison of salivary and calculated free cortisol levels during low and standard dose of ACTH stimulation tests in healthy volunteers.

Authors:  Gulsah Elbuken; Fatih Tanriverdi; Zuleyha Karaca; Mustafa Kula; Selma Gokahmetoglu; Kursad Unluhizarci; Fahrettin Kelestimur
Journal:  Endocrine       Date:  2014-08-13       Impact factor: 3.633

6.  Can a glucagon stimulation test characterized by lower GH cut-off value be used for the diagnosis of growth hormone deficiency in adults?

Authors:  Halit Diri; Zuleyha Karaca; Yasin Simsek; Fatih Tanriverdi; Kursad Unluhizarci; Ahmet Selcuklu; Fahrettin Kelestimur
Journal:  Pituitary       Date:  2015-12       Impact factor: 4.107

7.  Revised GH and cortisol cut-points for the glucagon stimulation test in the evaluation of GH and hypothalamic-pituitary-adrenal axes in adults: results from a prospective randomized multicenter study.

Authors:  Amir H Hamrahian; Kevin C J Yuen; Murray B Gordon; Karen J Pulaski-Liebert; James Bena; Beverly M K Biller
Journal:  Pituitary       Date:  2016-06       Impact factor: 4.107

8.  Revisiting peak serum cortisol response to insulin-induced hypoglycemia in children.

Authors:  J B Drummond; B S Soares; W Pedrosa; A Ribeiro-Oliveira
Journal:  J Endocrinol Invest       Date:  2020-09-21       Impact factor: 4.256

Review 9.  Clinical and diagnostic approach to patients with hypopituitarism due to traumatic brain injury (TBI), subarachnoid hemorrhage (SAH), and ischemic stroke (IS).

Authors:  Ioannis Karamouzis; Loredana Pagano; Flavia Prodam; Chiara Mele; Marco Zavattaro; Arianna Busti; Paolo Marzullo; Gianluca Aimaretti
Journal:  Endocrine       Date:  2015-11-16       Impact factor: 3.633

10.  Growth hormone and cortisol secretion in the elderly evaluated using the glucagon stimulation test.

Authors:  Ana Beatriz Winter Tavares; Ignácio Antônio Seixas-da-Silva; Diego H S Silvestre; Maria Fernanda Castelar Pinheiro; Mario Vaisman; Flávia Lucia Conceição
Journal:  Endocrine       Date:  2017-03-11       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.